Volume 5, Problème 5 (2008)
Perspective
HIV drug policies and South markets: settling controversies
Daniele Dionisio, Claudio Fabbri and Daniela Messeri
article de recherche
Study of the extraction, purification and antidiabetic potential of ursolic acid from Cornus officinalis Sieb. et Zucc.
Dawei Gao, Na Li, Qingwang Li, Jian Li, Zengsheng Han, Yusheng Fan and Zhiwei Liu
Article de révision
Endoplasmic reticulum stress response as a potential therapeutic target in multiple sclerosis
Meghann Teague Getts, Daniel R Getts, Adam P Kohm and Stephen D Miller
Article de révision
Pharmacogenomics in multiple sclerosis: getting the right medicine to the right patient
Manuel Comabella
Article de révision
Novel designs for clinical trials in multiple sclerosis: another excursion to Sirenum scopuli?
Stacey S Cofield and Gary R Cutter
Évaluation des médicaments
Dirucotide (MBP8298) for the treatment of multiple sclerosis
Clyde Markowitz
Évaluation des médicaments
Desmopressin for the treatment of adult nocturia
Hashim Hashim and Paul Abrams
Évaluation des documents prioritaires
Efficacy of tocilizumab, a humanized anti-IL-6 receptor antibody, in rheumatoid arthritis
Yoshiyuki Ohsugi
Éditorial
What are new therapies teaching us about the immunology of multiple sclerosis?
Michael K Racke and Amy E Lovett-Racke
Avant-propos
Multiple sclerosis therapeutics: opportunities, strategies and challenges
Richard A Rudick
